Search research articles
Contact Us
Filters
Showing results (131-140 of 251) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study
O Hartmann, E Benhamou, F Beaujean, et al.
Journal of Neuro-Oncology
|
January 1, 1996
Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1984
Acute leukemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumors
O Hartmann, O Oberlin, J Lemerle, et al.
Bulletin Du Cancer
|
March 1, 1997
[High-dose chemotherapy in relapse of medulloblastoma in young children]
S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Cancer
|
February 15, 1996
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system
A Suc, J Lumbroso, H Rubie, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
December 5, 2002
[Pseudotumoral diseases: ten years of experience in a pediatric oncology department]
G Raimondo, V Ridola, L Brugières, et al.
Bone Marrow Transplantation
|
August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in children
J Grill, M C Le Deley, D Valteau-Couanet, et al.
Bone Marrow Transplantation
|
April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma
D Valteau-Couanet, G Vassal, C Pondarré, et al.
Bone Marrow Transplantation
|
October 3, 1998
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors
N Lucidarme, D Valteau-Couanet, O Oberlin, et al.
Blood
|
May 1, 1992
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?
G Vassal, A Deroussent, D Challine, et al.
Page
of 26
Search research articles
Search
Showing results (131-140 of 251) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1986
High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study
O Hartmann, E Benhamou, F Beaujean, et al.
Journal of Neuro-Oncology
|
January 1, 1996
Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1984
Acute leukemia in two patients treated with high-dose melphalan and autologous marrow transplantation for malignant solid tumors
O Hartmann, O Oberlin, J Lemerle, et al.
Bulletin Du Cancer
|
March 1, 1997
[High-dose chemotherapy in relapse of medulloblastoma in young children]
S Dupuis-Girod, O Hartmann, E Benhamou, et al.
Cancer
|
February 15, 1996
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system
A Suc, J Lumbroso, H Rubie, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
December 5, 2002
[Pseudotumoral diseases: ten years of experience in a pediatric oncology department]
G Raimondo, V Ridola, L Brugières, et al.
Bone Marrow Transplantation
|
August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in children
J Grill, M C Le Deley, D Valteau-Couanet, et al.
Bone Marrow Transplantation
|
April 1, 1996
Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma
D Valteau-Couanet, G Vassal, C Pondarré, et al.
Bone Marrow Transplantation
|
October 3, 1998
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors
N Lucidarme, D Valteau-Couanet, O Oberlin, et al.
Blood
|
May 1, 1992
Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?
G Vassal, A Deroussent, D Challine, et al.
Page
of 26